Biotech · 5 min read

Cyber Insurance for Biotech & Life Sciences

Biotech and life-sciences companies are valued largely on information: proprietary research, R&D data, and clinical-trial results that took years and significant capital to produce. That intellectual property is exactly what attackers want, and a breach or ransomware event can do more than expose data — it can freeze lab systems and set research timelines back. Cyber insurance for biotech is how you fund the response when sensitive research data is compromised and the business interruption that follows. Even pre-revenue companies carry meaningful exposure through employee data, investor data, and research-partner relationships. IBM's Cost of a Data Breach 2026 puts the global average breach at $4.99M, a figure that resonates when the data at risk underpins your entire valuation. This guide covers the cyber exposures specific to biotech and life-sciences companies, the contract and partner requirements you'll encounter, and what underwriters review. The aim is coverage that protects the research data and systems your company is built on.

The Cyber Exposures Specific to Biotech

Biotech risk is driven by the value of research data and the disruption an incident causes — not high-volume consumer records.

  • IP and R&D data theft. Proprietary research, compound data, and methods are high-value targets; theft can erode competitive position and investor confidence in a way that's hard to undo.
  • Clinical-trial data exposure. Companies running trials handle sensitive personal and health-related data, raising both breach severity and regulatory duties.
  • Ransomware and lab-system interruption. Sophos's research puts the median ransom paid at roughly $1M and average recovery around $1.53M; in biotech, ransomware can freeze lab and research systems and delay timelines that funding depends on.
  • Partner and employee data. Even pre-revenue biotechs hold employee, investor, and research-partner data that triggers breach-notification duties when compromised.

For how first-party and third-party cyber coverage fit together, see our primer on cyber insurance for small businesses.

Research Partners, Contracts, and Regulatory Duties

Biotech companies sit in a web of collaborations — sponsored research, CRO relationships, and academic partnerships — that put third-party data in your hands and bring contractual insurance requirements with it.

  • Collaboration and sponsored-research agreements. These frequently include indemnification and insurance requirements that a cyber policy needs to satisfy, sometimes with named-insured or additional-insured status.
  • Clinical-trial and health-data obligations. Where you handle health-related personal data, HIPAA and state health-data laws can apply; several states have broadened their breach-notification rules — for example, Pennsylvania's Breach of Personal Information Notification Act, expanded in 2023–2024 to include medical and health-insurance information.
  • State breach-notification laws. Wherever your employees, investors, and partners reside, you inherit that state's notification duties when their personal information is breached.

Regulatory defense coverage — responding to investigations and, where insurable, fines and penalties — and contingent business-interruption coverage for partner systems are parts of the cyber policy biotech buyers should scrutinize.

Limits and What Underwriters Review

Cyber insurance is often a contractual gate in biotech, both for research partners and for later-stage investors.

  • Limits. Collaboration and enterprise agreements commonly reference $1M–$5M of cyber coverage, sometimes alongside other lines, with additional-insured status and a current certificate of insurance.
  • Controls underwriters expect. MFA everywhere, tested and segregated backups (critical for protecting research data), modern endpoint detection, network segmentation between lab/research and corporate systems, and a documented incident-response plan.
  • Attestations. SOC 2 is not insurance, but the controls it verifies earn better cyber pricing and give underwriters independent evidence your safeguards operate.

Premiums vary with the sensitivity of your data, your stage, and your controls, but as of 2026 typical market ranges for early-stage biotech run from the low four figures upward, scaling with limits and data sensitivity. These are market ranges as of 2026, not a quote. Cyber is also one piece of a broader program — most funded biotechs buy it alongside D&O, which we cover in our startup insurance guide.

Get a Biotech Cyber Insurance Quote from OnePark Risk

OnePark Risk places cyber, D&O, and tech E&O coverage for venture-backed biotech and life-sciences companies, and we understand research-data exposure, collaboration-agreement requirements, and what investors expect. Request a cyber insurance quote and we'll return options matched to your stage, data profile, and partner requirements.

Frequently asked questions

Does a pre-revenue biotech need cyber insurance?

Often yes. Even without customer revenue, biotechs hold valuable research IP plus employee, investor, and partner data, and they face ransomware that can freeze lab systems. Research collaboration agreements also frequently require cyber coverage before data is shared.

Does cyber insurance cover stolen research data and IP?

Cyber policies fund the breach response — forensics, notification where personal data is involved, and certain liability — and can respond to business interruption from an attack. Coverage for the underlying loss of trade-secret value is more limited and varies by policy, so the terms are worth reviewing closely with your broker.

How much cyber insurance does a biotech need?

Start with what your research-partner and collaboration agreements require — these commonly reference $1M–$5M. Beyond contracts, weigh the value of your research data and what a multi-week lab-system outage would cost in delayed timelines.

Do research collaboration agreements require cyber insurance?

Frequently, yes. Sponsored-research, CRO, and academic-collaboration agreements often include indemnification and insurance requirements, sometimes asking for additional-insured status and a current certificate of insurance before data is shared.

This material is general educational information, not legal, tax, or insurance advice. Coverage availability, policy terms, and regulatory requirements vary by state, carrier, and applicant.